ClinicalTrials.gg
Enrolling by invitationNCT07673198Updated Oct 28, 2026

Effects of Semantic Context on Criterion-learning Naming Treatment in Aphasia

An interventional study of Criterion-learning practice in Aphasia, sponsored by Albert Einstein Healthcare Network. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Albert Einstein Healthcare Network · Not applicable, Interventional, and Treatment

Updated Oct 28, 2026Now Enrolling by invitationStart date movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
18 Years to 89 Years
Sex
All
01

Study summary

Aphasia is a disorder of spoken and written language, most commonly following a stroke. It is estimated that between 2.5 and 4 million Americans are living with aphasia today. A common problem in aphasia involves difficulty retrieving known words in the course of language production and comprehension. The overarching goal of this project is to develop and test early efficacy, efficiency, and the tolerability of a lexical treatment for aphasia in multiple-session regimens that are comprised of retrieval practice, distributed practice, and training dedicated to the elicitation of correct retrievals. The aim of this work is to add to and refine the evidence base for the implementation and optimization of these elements in the treatment of production and comprehension deficits in aphasia, and make important steps towards an ultimate goal of self-administered lexical treatment grounded in retrieval practice principles (RPP) to supplement traditional speech-language therapy that is appropriate for People with Aphasia (PWA) from a broad level of severity of lexical processing deficit in naming and/or comprehension. This project cumulatively builds on prior work to develop a theory of learning for lexical processing impairment in aphasia that aims to ultimately explain why and for whom familiar lexical treatments work, and how to maximize the benefits they confer.

Read the detailed description

This study examines a retrieval practice-based naming treatment termed criterion learning. In criterion learning, each item's assigned criterion level dictates the number of times that item is correctly retrieved before it is dropped from further training within a session. Criterion learning optimally incorporates potent learning experiences, including spaced retrieval practice with emphasis on correct retrievals during training. The present study will provide critical observations for optimizing criterion learning for treating word processing deficits in people with aphasia. This study will recruit 12 community-dwelling individuals with aphasia, who will undergo comprehensive neuropsychological characterization. Subsequently, participants will engage in an experimental treatment designed to promote improvements in word retrieval deficits.

This study will examine whether making retrieval practice more effortful by increasing semantically-driven lexical competition enhances naming treatment benefit in a multiple-session naming treatment. This involves training items amidst related (e.g., for "dog," horse, cow, zebra) or unrelated items (e.g., for "dog," ambulance, pencil, rose). Each PWA will complete multiple training/test rounds--a round refers to the two training sessions separated by one or more days, and a retention test for those items. In some sessions, a desk-mounted eyetracker will be used to track eyegaze patterns as participants name pictures.

02

Conditions studied

  • Aphasia

Keywords

  • anomia
  • retrieval practice
  • word-finding problem
  • communication disorder
  • naming impairment
03

In context

Aphasia

338 studies on the registry are indexed under Aphasia; 95 are open to participants now.

This study's planned enrollment of 12 is below the median of 30 across 298 interventional studies indexed under Aphasia.

Browse Aphasia studies →

Lead sponsor

Albert Einstein Healthcare Network is the lead sponsor of 63 studies on the registry; 6 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 3 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • English as a native or primary language
  • Adults with stroke who are at least 6 months post-onset

Exclusion criteria

Exclusion Criteria:

  • History of comorbid neurological diagnoses, such as Multiple Sclerosis or Parkinson's Disease
  • History of a learning disability that significantly impacted language development, such as developmental language disorder
  • Insufficient stamina to participate in the protocol
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Criterion-learning practice

    This is a single-arm study

    Behavioral: Criterion-learning practice

Interventions

  • BehavioralCriterion-learning practice

    The experiments will be presented on a computer. On each criterion-learning trial, a picture is presented and the participant is asked to try to produce the name for the object with or without a cue. Correct-answer feedback is provided. Criterion learning involves presenting a block of items, and on each trial, the experimenter or a voice-recognition component will code the response during the trial as correct/incorrect. When the item reaches its assigned criterion level, it is dropped from further training in a session.

06

What researchers measure

Primary outcomes

  1. Trained naming items

    Confrontation naming task that involves trained items

    Time frame: approximately one-week following treatment

Other outcomes

  1. Trained naming items pupillometry

    Pupil size during naming

    Time frame: approximately one-week post-treatment

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Anonymized data and analysis code will be accessible on the Open Science Framework (OSF).

Supporting information: Analytic code

Time frame: 6 months following publication

Access criteria: Anonymized data and analysis code will be accessible on the Open Science Framework (OSF).

09

Updates

1 registry update since Sep 25, 2026
Status
Not yet recruiting→Enrolling by invitation
changed Oct 28, 2026
Start date
Aug 2026→Oct 20, 2026 (actual)
Oct 28, 2026
Contact
No study contact listed any more: removed k•••@jefferson.edu · •••6017
Oct 28, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Jefferson Moss Rehabilitation Research Institute · Elkins Park, United StatesContact removed k•••@jefferson.edu · •••6017
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    Not yet recruiting→Enrolling by invitation
    Start date Aug 2026→Oct 20, 2026 (now actual)
    Contact No study contact listed any more: removed k•••@jefferson.edu · •••6017
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Jefferson Moss Rehabilitation Research Institute · Elkins Park, United StatesContact removed k•••@jefferson.edu · •••6017
    + 2 other changes: verification date and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07673198
Lead sponsor
Albert Einstein Healthcare Network
Responsible party
Erica Middleton (Institute Scientist, Jefferson Moss Rehabilitation Research Institute, Albert Einstein Healthcare Network) — Principal investigator
First posted
Jun 29, 2026
Start date
Oct 20, 2026
Primary completion
Aug 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Oct 28, 2026

Study contacts

Erica Middleton, PhD
principal investigator · Albert Einstein Healthcare Network

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion